Xiaochun Lin

645 total citations
35 papers, 406 citations indexed

About

Xiaochun Lin is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Xiaochun Lin has authored 35 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Surgery and 9 papers in Cancer Research. Recurrent topics in Xiaochun Lin's work include MicroRNA in disease regulation (5 papers), Adipose Tissue and Metabolism (5 papers) and Cancer-related molecular mechanisms research (4 papers). Xiaochun Lin is often cited by papers focused on MicroRNA in disease regulation (5 papers), Adipose Tissue and Metabolism (5 papers) and Cancer-related molecular mechanisms research (4 papers). Xiaochun Lin collaborates with scholars based in China, Denmark and Trinidad and Tobago. Xiaochun Lin's co-authors include Meiping Guan, Shu Fang, Yudan Zhang, Yanmei Zeng, Chunyan Wu, Jin‐Yan Shang, Xiu Liu, Xiaofei Lv, Jia‐Guo Zhou and Sijia Liang and has published in prestigious journals such as Applied and Environmental Microbiology, Diabetes and Journal of Agricultural and Food Chemistry.

In The Last Decade

Xiaochun Lin

33 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaochun Lin China 12 201 104 75 50 48 35 406
Zhimei Lv China 12 234 1.2× 73 0.7× 55 0.7× 46 0.9× 26 0.5× 15 460
Jin‐Yan Shang China 10 254 1.3× 115 1.1× 56 0.7× 31 0.6× 34 0.7× 12 440
Songping Yu China 12 182 0.9× 65 0.6× 57 0.8× 55 1.1× 23 0.5× 25 398
Jiayu Jin China 8 321 1.6× 71 0.7× 72 1.0× 60 1.2× 33 0.7× 12 463
Xiaoling Yang China 17 351 1.7× 146 1.4× 73 1.0× 34 0.7× 36 0.8× 25 602
Shunlin Qu China 14 293 1.5× 123 1.2× 53 0.7× 35 0.7× 26 0.5× 21 470
Xiaofei Feng China 12 218 1.1× 71 0.7× 50 0.7× 59 1.2× 27 0.6× 31 458
Ke‐Xue Li China 12 207 1.0× 73 0.7× 83 1.1× 63 1.3× 34 0.7× 17 465
Dongyuan Xu China 13 240 1.2× 150 1.4× 51 0.7× 23 0.5× 57 1.2× 42 516
Shujian Wei China 11 183 0.9× 88 0.8× 85 1.1× 77 1.5× 28 0.6× 22 488

Countries citing papers authored by Xiaochun Lin

Since Specialization
Citations

This map shows the geographic impact of Xiaochun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochun Lin more than expected).

Fields of papers citing papers by Xiaochun Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaochun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochun Lin. The network helps show where Xiaochun Lin may publish in the future.

Co-authorship network of co-authors of Xiaochun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaochun Lin. A scholar is included among the top collaborators of Xiaochun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaochun Lin. Xiaochun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Lei, Peili Wu, Qing Li, et al.. (2025). NUAK1 Promotes Diabetic Kidney Disease by Accelerating Renal Tubular Senescence via the ROS/P53 Axis. Diabetes. 74(12). 2405–2417.
2.
Li, Xuelin, Min Luo, Yanmei Zeng, et al.. (2025). MicroRNA-24-3p targeting Top1 in perirenal fat is involved in circulating inflammation and high cardiovascular disease risk in patients with primary aldosteronism. Journal of Translational Medicine. 23(1). 345–345. 2 indexed citations
3.
Zhong, Jiahong, Yunyun Qin, Jinyu Xue, et al.. (2025). Inhibition of PDE4 Alleviates Endoplasmic Reticulum Stress and Neuronal Damage via Activation of Nrf2/HO-1 in Parkinson's Disease. Molecular Neurobiology. 63(1). 49–49.
4.
Wu, Tong Tong, Fangfang Zhan, Yanli Sun, et al.. (2025). Arginine accumulation suppresses heat production during fermentation of the biocontrol fungus Beauveria bassiana. Applied and Environmental Microbiology. 91(3). e0213424–e0213424. 3 indexed citations
5.
Lin, Xiaochun, Hao Lin, Jing Xu, Shouxing Yang, & Lei Miao. (2025). Relative fat mass as a predictor of gallstones: insights from national health and nutrition examination survey data. Lipids in Health and Disease. 24(1). 78–78. 2 indexed citations
6.
Li, Pan, et al.. (2024). A genomic instability-associated lncRNA signature for predicting prognosis and biomarkers in lung adenocarcinoma. Scientific Reports. 14(1). 14460–14460. 2 indexed citations
7.
Lin, Xiaochun, Yingying Zhang, Zhijun Xie, et al.. (2024). Necroptosis-related lncRNAs: biomarkers for predicting prognosis and immune response in lung adenocarcinoma. Translational Lung Cancer Research. 13(10). 2713–2728. 2 indexed citations
8.
Xie, Weiwei, Xinyuan Fang, Han Xu, et al.. (2023). Transcriptome Analysis Reveals the Response of Cryptomeria japonica to Feeding Stress of Dendrolimus houi Lajonquière Larvae. Forests. 15(1). 85–85. 1 indexed citations
9.
Lin, Xiaochun, Jiahui Su, Sijia Liang, et al.. (2022). Ponatinib modulates the metabolic profile of obese mice by inhibiting adipose tissue macrophage inflammation. Frontiers in Pharmacology. 13. 1040999–1040999. 5 indexed citations
10.
Zhang, Yudan, Yingying Cai, Hongbin Zhang, et al.. (2021). Brown adipose tissue transplantation ameliorates diabetic nephropathy through the miR-30b pathway by targeting Runx1. Metabolism. 125. 154916–154916. 24 indexed citations
11.
Li, Ping, Yingying Cai, Shu Fang, et al.. (2020). Transplantation of brown adipose tissue up-regulates miR-99a to ameliorate liver metabolic disorders in diabetic mice by targeting NOX4. Adipocyte. 9(1). 57–67. 24 indexed citations
12.
Fang, Shu, Ping Li, Yudan Zhang, et al.. (2020). MiR-455 targeting SOCS3 improve liver lipid disorders in diabetic mice. Adipocyte. 9(1). 179–188. 11 indexed citations
13.
Lin, Xiaochun, et al.. (2020). Prognostic and clinicopathological value of PD-L2 in lung cancer: A meta-analysis. International Immunopharmacology. 91. 107280–107280. 10 indexed citations
14.
Lv, Xiaofei, Yajuan Zhang, Xiu Liu, et al.. (2020). TMEM16A ameliorates vascular remodeling by suppressing autophagy via inhibiting Bcl-2-p62 complex formation. Theranostics. 10(9). 3980–3993. 31 indexed citations
15.
Lin, Xiaochun, et al.. (2020). Prognostic and clinicopathological utility of PD-L2 expression in patients with digestive system cancers: A meta-analysis. International Immunopharmacology. 88. 106946–106946. 7 indexed citations
16.
Li, Kai, Xiaofei Lv, Tingting Zhang, et al.. (2020). Reduced intracellular chloride concentration impairs angiogenesis by inhibiting oxidative stress-mediated VEGFR2 activation. Acta Pharmacologica Sinica. 42(4). 560–572. 14 indexed citations
17.
Lin, Xiaochun, Dian Huang, Tongtong Pan, et al.. (2020). 1H NMR-based metabolomics analyses in children with Helicobacter pylori infection and the alteration of serum metabolites after treatment. Microbial Pathogenesis. 147. 104292–104292. 6 indexed citations
18.
Wu, Chunyan, Huijian Zhang, Hongbin Zhang, et al.. (2019). Increased oxidative stress, inflammation and fibrosis in perirenal adipose tissue of patients with cortisol-producing adenoma. Adipocyte. 8(1). 347–356. 16 indexed citations
19.
Liu, Xiaoyun, Feiran Zhang, Jin‐Yan Shang, et al.. (2018). Renal inhibition of miR-181a ameliorates 5-fluorouracil-induced mesangial cell apoptosis and nephrotoxicity. Cell Death and Disease. 9(6). 610–610. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026